secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moderna, Inc. (MRNA)
CIK:        0001682852
Form:       8-K
Filed at:   2022-09-29T23:59:59+00:00
Accession:  0001682852-22-000045
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moderna appoints Andres to new President role, Collins as CTOQO effective Jan 1, 2023
--------------------------------------------------------------------------------

- Juan Andres transitions to President, Strategic Partnerships and Enterprise Expansion; retains Executive Committee seat.
- Jerh Collins joins as Chief Technical Operations & Quality Officer, effective Jan 1, 2023; from Novartis with 30 yrs manufacturing experience.
- Executive Committee expanded to prepare for multiple new product launches; Andres led COVID vaccine production.
- Collins will focus on expanding production footprint globally; starts Oct 3, 2022, assumes role Jan 1, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682852/000168285222000045/0001682852-22-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682852/000168285222000045/mrna-20220929.htm
  HTML page:      https://secwatch.observer/filing/0001682852-22-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer